Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Document › Details

MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY.

	Organisation	MeiraGTx Holdings Plc (NASDAQ: MGTX)
	Group	MeiraGTx (Group)
	Organisation 2	Janssen Pharmaceuticals Inc.
	Today	Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals Inc.)
	Group	Johnson & Johnson (JnJ) (Group)
	Product	AAV-CNGA3 gene therapy (MeiraGTx)
	Product 2	AAV-hAQP1 gene therapy (MeiraGTx)
	Index term	JnJ–MeiraGTx: gene therapy, 201901– collab RnD + license ww excl $100m upfront + milestones + funding + 20% royalties for inherited retinal diseases
	Person	Forbes, Alexandria (MeiraGTx 201810 CEO)
	Person 2	Pascale, Christiana (W2O Group 201901 at W2O pure)

Original document
accessed by [iito] on 2019-08-08

Record changed: 2023-06-05

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for MeiraGTx (Group)

[1] MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY....
[2] MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY....
[3] MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY....
[4] MeiraGTx Holdings plc. (11/19/20). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY....
[5] MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY....
[6] MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY....
[7] MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY....
[8] MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY....
[9] MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY....
[10] MeiraGTx Holdings plc. (5/6/19). "Press Release: MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference". London & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]